Trials / Withdrawn
WithdrawnNCT02985632
A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
Single-dose Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
An oral dose of BMS-986141 administered in Hepatic Impairment and Healthy Participants to evaluate pharmacokinetics in this patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986141 |
Timeline
- Start date
- 2017-01-11
- Primary completion
- 2017-05-18
- Completion
- 2017-07-07
- First posted
- 2016-12-07
- Last updated
- 2017-02-06
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02985632. Inclusion in this directory is not an endorsement.